To promote the work of its member centers, AACI publishes Commentary, an editorial series focusing on major issues of common interest to North American cancer centers.
Each AACI Commentary is written by a cancer center leader or subject matter expert and distributed by email to the more than 2,500 readers of the AACI Update newsletter.
The publication is designed to cover a specific topic in 750-1,000 words. Recommendations for topics and authors are encouraged.
By Theresa L. Werner, MD
When AACI’s Clinical Research Innovation (CRI) Steering Committee convened last fall to plan the 12th Annual AACI CRI Meeting, we mapped out a robust, three-day meeting centered on the future of clinical research. I think it’s safe to say that in November, none of us anticipated how quickly our vision for the future would change.
Since the COVID-19 pandemic was declared in March, AACI cancer centers pivoted to create a "new normal." The pandemic has reshaped everyone’s lives, affecting everything from the way we work and interact with our colleagues to the way we conduct cancer clinical research.
Recognizing the enormous impact of COVID-19, the steering committee designed an updated agenda for a two-day, virtual meeting that focused on the challenges posed by the pandemic — and the creative, innovative solutions implemented by AACI cancer centers.
Read the July 2020 Commentary.
Reflections on the 12th Annual AACI CRI Meeting
By Theresa L. Werner, MD
Localizing Data to Expand Community Participation in Clinical Trials
By Robert Winn, MD
COVID-19: How AACI’s Corporate Partners Are Helping Cancer Centers and Their Patients Weather the Pandemic
COVID-19: What AACI Cancer Centers Are Doing to Mitigate Risks
By AACI Staff
Perspectives From the NCI Director: Homecoming and the NCI FY 2020 Budget
By Norman E. Sharpless, MD
Looking Ahead: Forging a Path for 2020 and Beyond
By Jennifer W. Pegher, MA
Bridging the Cost Chasm: Empowering Clinical Trials Offices to Negotiate With Industry Partners
By Aleksandar Zafirovski, MBA
Artificial Intelligence, Workforce Training, Patient Advocacy & More: Reflections on the 2019 AACI/CCAF Annual Meeting
By Michael B. Kastan, MD, PhD
Less Paper, Better Trials: Recommendations for Implementing an Electronic Regulatory Document Management System
By the AACI Regulatory File Management Working Group
A Future Without HPV-Related Cancers is Within Reach: Eliminating Cervical Cancer is the First Step
By Anna R. Giuliano, PhD
Simplifying Clinical Trials: Using Technology to Improve Operations
By the AACI Shared Investigator Platform (SIP) Task Force
Disclose and Manage: Recommendations From the AACI Conflict of Interest Task Force
By Karen E. Knudsen, MBA, PhD, and Leonidas C. Platanias, MD, PhD
Inventing the Future of Oncology Nursing
By Laura Fennimore, DNP, RN, NEA-BC
Ensuring Patient Access to CAR T Therapy: AACI Responds to CMS Medicare Coverage Proposal
By Richard Bondi and Clint Divine
A Revolution in Cancer Care: AACI's New Initiative Will Establish Best Practices in CAR T Therapy
By Joseph McGuirk, DO
A Legislation Library to Benefit AACI Cancer Centers
By Roy A. Jensen, MD
Zip Code vs. Genetic Code: Breaking Down Cancer Disparities in Philadelphia
By Karen E. Knudsen, PhD
Satisfaction with Oncology Quality and Clinical Operations: A survey from the AACI Physician Clinical Leadership Initiative (PCLI)
By Morgan Dodson, Michael Neuss, Laura Hutchins, Richard Lauer, John Sweetenham, Nathan Levitan, Martha Mims, Mohammed Milhem, Craig Bunnell, Dan Mulkerin, Randall F. Holcombe
SF CAN: A City Working Together to Fight Cancer
By Alan Ashworth, PhD, FRS
Integrating Clinical Research into Clinical Care
By Martha Mims, MD, PHD & Sarah McNees, PHD